Jason Daniel Speake

USPTO Granted Patents = 10 (Patent Applications = 1)

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Cary, NC (US) (2008 - 2014)
Research Triangle Park, NC (US) (2014)
Durham, NC (US) (2005 - 2023)

Company Filing History:

Smithkline Beecham Corporation

patents

2 out of 70

Anacor Pharmaceuticals, Inc.

patents

4. 2 out of 8,684

US Government As Represented by the Secretary of the Army

Novartis Vaccines & Diagnostics, Gmbh

patents

where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11691992 - Oxaborole analogs and uses thereof (2023-07-04),

2. 10961261 - Oxaborole analogs and uses thereof (2021-03-30),

3. 8822518 - Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction (2014-09-02),

4. 8633175 - Compounds as antagonists or inverse agonists at opioid receptors (2014-01-21),

5. 7939528 - Heterocycle compounds (2011-05-10),

6. 7625909 - Substituted quinazolinone compounds (2009-12-01),

7. 7442693 - Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors (2008-10-28),

8. 7368453 - Quinazolinone compounds with reduced bioaccumulation (2008-05-06),

9. 7285557 - Pyrimidinones as melanin concentrating hormone receptor 1 (2007-10-23),

10. 6884801 - Imidazoline derivatives as alpha-1A adrenoceptor ligands (2005-04-26),

Title: Jason Daniel Speake: Innovator in Pharmaceutical Research

Introduction

Jason Daniel Speake is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical research, holding a total of 10 patents. His work primarily focuses on developing compounds that address diseases caused by parasites.

Latest Patents

Among his latest patents is the application titled "Oxaborole analogs and uses thereof." This application describes compounds, compositions, and methods that are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of diseases caused by parasites. This innovative approach showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Jason has worked with notable companies such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.

Collaborations

Jason has collaborated with esteemed colleagues, including Michael Joseph Bishop and David John Cowan. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Jason Daniel Speake is a dedicated inventor whose work in pharmaceutical research has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.